To investigate the action of pentoxifylline (PTX) and prostaglandin E1 (PGE1) on ischemia and reperfusion of small intestine tissue in rats, using immunohistochemical analysis.
Owing to their antioxidative ability, pentoxifylline (PTX) and prostaglandin E1 (PGE1) directly inhibit superoxide anions, which indirectly block the action of xanthine oxidase. In addition, they appear to decrease inflammatory response by reducing neutrophil migration, as well as other mechanisms that participate in inflammation, involving, for instance, the release of cytokines, tumor necrosis factor, platelet activating factor, and endothelin, a potent vasoconstrictor. In addition, PGE1 has strong vasodilating action and plays a role in activating fibrinolysis and modulating cell proliferation, as well as in fibrogenesis, angiogenesis, and tissue fibrinolysis 11, 12 .
Considering these aspects, the purpose of the present study was to perform an immunohistochemical evaluation of PTX and PGE1 ability to attenuate lesions in the small intestine of rats subjected to ischemia and reperfusion. Anti-FAS ligand was employed as a biomarker of cell death by apoptosis.
Methods

The research was approved by the Committee for Ethics in Research in Humans, UFMS (permit 308).
Thirty-five adult male albino Wistar rats (Rattus norvegicus) of 260g mean weight were assigned to four groups (GA-GD), as follows: GA, n=10; GB, n=10; GC, n=10; and GD, n=5. The animals in GA were subjected to 60 min ischemia followed by 60 min reperfusion (as described in the next topic), but were given no test drugs 13 ; GB animals underwent ischemia and reperfusion with PTX at 40 mg kg -1 distributed as 20 mg kg -1 given 3 min before the beginning of ischemia and 20 mg kg -1 given 3 min before reperfusion; GC animals underwent ischemia and reperfusion with PGE1 at 5 μg kg -1 distributed as 2.5 μg kg -1 given 3 min before the beginning of ischemia and 2.5 μg kg -1 given 3 min before reperfusion; GD animals (sham group) were subjected to all experimental procedures-i.e., analgesia, anesthesia, and laparotomy-except clamping of the mesenteric artery or drug use.
Tissue ischemia and reperfusion procedures
All animals were anesthetized had the ventral skin aseptically prepared while lying on a dorsal position and were subjected to median xyphopubic laparotomy for access to the superior mesenteric artery. In GA, GB, and GC animals, this artery was clamped and the abdomen was sutured with nylon 3-0
. The artery remained clamped for 60 min. Anesthetization was subsequently repeated in the same dose, the abdominal cavity was opened by cutting the sutures, the small intestine was exposed, the vascular clamp was removed to restore blood flow, and the intestine was repositioned and allowed to reperfuse for 60 min.
Tissue collection for immunohistochemistry
After reperfusion, all animals were again anesthetized for suture removal and resection of a roughly 2 cm-long segment of the ileum, 5 cm proximal to the ileocecal junction. The segment was washed with saline solution and 10% formaldehyde and fixed in 10% buffered formalin for subsequent immunohistochemical processing. The animals were then euthanized by aortic exsanguination while under anesthesia.
Immunohistochemical processing
Immunohistochemical processing (using the avidinbiotin complex method, ABC) was carried out at the Screenlab Laboratório, Campo Grande-MS, using primary anti-FAS ligand antibody (epitope terminus N20; Santa Cruz, product SC834, lot The Kolmogorov-Smirnov test was applied, followed by analysis of variance (ANOVA) with Tukey's post-test. A significance level of p≤0.05 was adopted.
Results Table 1 shows the results obtained.
The average number of cells expressing anti-FAS ligand in the crypts was highest in GA animals (78.9 ± 17.3), followed by those in GB (16.7 ± 2.8), GC (11.3 ± 1.8), and GD (2.5 ± 0.9), with very significant differences across groups (p<0.0001) (Figures 1 and 2 ). 
GA
Discussion
In cases of ischemia of the small intestine, prompt restoration of blood flow is crucial, yet it can lead to further damage to the lesions formed during ischemia. Animal models capable of reproducing the ischemic conditions found in humans have been investigated, in an effort to elucidate the pathophysiology of ischemia-reperfusion and develop alternative therapies 14, 15 . In the present investigation, obstruction of the superior mesenteric artery alone was the approach chosen to simulate the conditions of acute ischemia of the human intestinal artery, of frequent occurrence in clinical practice.
Damage control in cases of ischemia-reperfusion of the small intestine after acute arterial ischemia or intestinal transplant require drugs capable of reducing the release of reactive oxygen species, limiting neutrophil-mediated inflammatory response and curbing the release of tumor necrosis factor and all mediators of the complex inflammatory response involved in this phenomenon.
Previous studies conducted by our group, involving histological examination of slides stained with hematoxylin-eosin and statistical treatment of scores based on the criteria set by Chiu et al. 16 demonstrated that PTX and PGE1, separately administered to different groups, attenuated intestinal mucosa lesions caused by tissue ischemia-reperfusion 13 .
In the present study, immunohistochemical examination revealed positive expression of anti-FAS ligand, demonstrating it to be an efficient marker of cell apoptosis. In the control group (GA), cell apoptosis and high expression of the ligand predominated, corroborating the findings of other investigations [17] [18] [19] .
In contrast, use of PTX or PGE1 lowered anti-FAS ligand expression and promoted epithelial renewal, demonstrating the favorable effects of these drugs against cell apoptosis in cases of ischemia-reperfusion.
In the sham group (GD), anti-FAS ligand expression was low, possibly indicating the occurrence of physiological epithelial renewal, more frequent at epithelial villus tips 17, 19, 20 .
PGE1 led to more favorable results than PTX, both in histological and immunohistochemical terms, despite the absence of significant differences. This superior performance of PGE1 may stem from properties such as fibrinolysis, angiogenesis, and strong vasodilation, which appear to mitigate the pathophysiological lesions caused by ischemia-reperfusion.
Conclusions
Pentoxifylline and prostaglandin E1 attenuated mucosal lesions caused by ischemia-reperfusion of the small intestine of rats. Anti-FAS ligand proved an effective marker for the immunohistochemical identification of cell death by apoptosis in the small intestine of rats.
